<p>Two pathways for the production of amyloid plaques are displayed. One involves the formation of neuritic plaques, which are characterized by the presence of densely packed Aβ fibrils, dystrophic neurites, reactive gliosis (astrocytes), extracellular filaments, activated microglial, and numerous other proteins. It is hypothesized that this neuritic plaque results from increased neuronal binding of Aβ, which forms fibrils that result in damaged neurons that follow a destructive pathway ultimately leading to the formation of the neuritic plaque. In contrast, Aβ that is not taken up by neurons forms Aβ protofibrils and fibrils and follows a protective pathway that results in the formation of diffuse/compact/dense core plaques. Substitution o...
Alzheimer\u27s disease (AD) is a late onset neurodegenerative disease characterized by memory loss a...
The deposition of amyloid-β peptides (Aβ) in senile plaques (SPs) is a central pathological feature ...
Amyloid plaques appear early during Alzheimer’s disease (AD), and their development is intimately li...
Amyloid plaques and neurofibrillary tangles (NFTs) in the brain are the neuropathological hallmarks ...
During the past few years, an increasing set of evidence has supported the major role of deregulatio...
The cause of the degeneration of nerve cells, and the loss of specific synaptic connections, that u...
Alzheimer’s disease is a major cause of dementia in the elderly and is a global health concern. Howe...
The cause of the initial synaptic disconnection and eventual widespread neuronal degeneration that u...
Aβ plaques are one of the two lesions in the brain that define the neuropathological diagnosis of Al...
Cumulative evidence in brains and cultured neurons of Alzheimer's disease (AD) transgenic mouse mode...
Alzheimer’s disease (AD) is chronic neurodegenerative dementia representing the most common cause of...
The deposition of aggregated amyloid β-protein (Aβ) in the human brain is a major lesion in Alzheime...
The Aβ peptide, the major constituent of senile plaques characteristic of Alzheimer\u27s disease (AD...
abstract: As Alzheimer’s disease (AD) increases in incidence, there is an increased investigation in...
International audienceAbstract Alzheimer's disease (AD) is characterized by intracerebral accumulati...
Alzheimer\u27s disease (AD) is a late onset neurodegenerative disease characterized by memory loss a...
The deposition of amyloid-β peptides (Aβ) in senile plaques (SPs) is a central pathological feature ...
Amyloid plaques appear early during Alzheimer’s disease (AD), and their development is intimately li...
Amyloid plaques and neurofibrillary tangles (NFTs) in the brain are the neuropathological hallmarks ...
During the past few years, an increasing set of evidence has supported the major role of deregulatio...
The cause of the degeneration of nerve cells, and the loss of specific synaptic connections, that u...
Alzheimer’s disease is a major cause of dementia in the elderly and is a global health concern. Howe...
The cause of the initial synaptic disconnection and eventual widespread neuronal degeneration that u...
Aβ plaques are one of the two lesions in the brain that define the neuropathological diagnosis of Al...
Cumulative evidence in brains and cultured neurons of Alzheimer's disease (AD) transgenic mouse mode...
Alzheimer’s disease (AD) is chronic neurodegenerative dementia representing the most common cause of...
The deposition of aggregated amyloid β-protein (Aβ) in the human brain is a major lesion in Alzheime...
The Aβ peptide, the major constituent of senile plaques characteristic of Alzheimer\u27s disease (AD...
abstract: As Alzheimer’s disease (AD) increases in incidence, there is an increased investigation in...
International audienceAbstract Alzheimer's disease (AD) is characterized by intracerebral accumulati...
Alzheimer\u27s disease (AD) is a late onset neurodegenerative disease characterized by memory loss a...
The deposition of amyloid-β peptides (Aβ) in senile plaques (SPs) is a central pathological feature ...
Amyloid plaques appear early during Alzheimer’s disease (AD), and their development is intimately li...